\BOOKMARK [1][-]{section.1}{Open Source Value Project}{}% 1
\BOOKMARK [1][-]{section.2}{Purpose}{}% 2
\BOOKMARK [2][-]{subsection.2.1}{Value assessment}{section.2}% 3
\BOOKMARK [2][-]{subsection.2.2}{Evaluation of scientific uncertainty}{section.2}% 4
\BOOKMARK [1][-]{section.3}{Components}{}% 5
\BOOKMARK [1][-]{section.4}{Model structure}{}% 6
\BOOKMARK [2][-]{subsection.4.1}{Disease model}{section.4}% 7
\BOOKMARK [2][-]{subsection.4.2}{Adverse events}{section.4}% 8
\BOOKMARK [2][-]{subsection.4.3}{Cost and utility}{section.4}% 9
\BOOKMARK [2][-]{subsection.4.4}{Patient heterogeneity}{section.4}% 10
\BOOKMARK [2][-]{subsection.4.5}{Rationale for individual-level simulation}{section.4}% 11
\BOOKMARK [1][-]{section.5}{Model outcomes}{}% 12
\BOOKMARK [2][-]{subsection.5.1}{Health outcomes}{section.5}% 13
\BOOKMARK [2][-]{subsection.5.2}{Risks}{section.5}% 14
\BOOKMARK [2][-]{subsection.5.3}{Costs}{section.5}% 15
\BOOKMARK [2][-]{subsection.5.4}{Value assessment}{section.5}% 16
\BOOKMARK [1][-]{section.6}{Source data and parameter estimation}{}% 17
\BOOKMARK [1][-]{section.7}{Simulation and uncertainty analysis}{}% 18
\BOOKMARK [2][-]{subsection.7.1}{Parameter uncertainty}{section.7}% 19
\BOOKMARK [2][-]{subsection.7.2}{Structural uncertainty}{section.7}% 20
\BOOKMARK [2][-]{subsection.7.3}{Implementation}{section.7}% 21
\BOOKMARK [1][-]{section*.2}{Appendices}{}% 22
\BOOKMARK [1][-]{Appendix.1.A}{Systematic literature review}{}% 23
\BOOKMARK [2][-]{subsection.1.A.1}{Treatment effects}{Appendix.1.A}% 24
\BOOKMARK [2][-]{subsection.1.A.2}{Utilities}{Appendix.1.A}% 25
\BOOKMARK [2][-]{subsection.1.A.3}{Resource use, productivity, and cost}{Appendix.1.A}% 26
\BOOKMARK [2][-]{subsection.1.A.4}{Study identification}{Appendix.1.A}% 27
\BOOKMARK [2][-]{subsection.1.A.5}{Study selection}{Appendix.1.A}% 28
\BOOKMARK [2][-]{subsection.1.A.6}{Data collection}{Appendix.1.A}% 29
\BOOKMARK [2][-]{subsection.1.A.7}{Limitations}{Appendix.1.A}% 30
\BOOKMARK [1][-]{Appendix.1.B}{Network meta-analysis}{}% 31
\BOOKMARK [2][-]{subsection.1.B.1}{Population, interventions, outcomes of interest}{Appendix.1.B}% 32
\BOOKMARK [2][-]{subsection.1.B.2}{Feasibility assessment}{Appendix.1.B}% 33
\BOOKMARK [2][-]{subsection.1.B.3}{Evaluation of consistency between direct and indirect comparisons}{Appendix.1.B}% 34
\BOOKMARK [2][-]{subsection.1.B.4}{Estimation of the relative treatment effects under the assumption of consistency}{Appendix.1.B}% 35
\BOOKMARK [2][-]{subsection.1.B.5}{Models, likelihood, priors}{Appendix.1.B}% 36
\BOOKMARK [3][-]{subsubsection.1.B.5.1}{Progression-free survival and overall survival}{subsection.1.B.5}% 37
\BOOKMARK [2][-]{subsection.1.B.6}{Model selection}{Appendix.1.B}% 38
\BOOKMARK [2][-]{subsection.1.B.7}{Software}{Appendix.1.B}% 39
\BOOKMARK [1][-]{References.1}{References}{}% 40
